Literature DB >> 6257327

Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat.

D Le Bars, D Chitour, E Kraus, A H Dickenson, J M Besson.   

Abstract

Twenty-eight convergent neurones, responding to both noxious and innocuous stimuli applied to their cutaneous receptive fields were recorded at the lumbar level in anaesthetized intact rats. These cells received Aa and C fibre inputs as shown by electrical stimulation of their receptive fields, and were located in the medial part of the dorsal horn. (a) For 15 units, Diffuse Noxious Inhibitory Controls (DNCI)67,68 were investigated by applying noxious thermal stimuli (52 degrees C) to the distal two-thirds of the tail. This conditioning stimulus induced strong inhibition of the responses to both Aa (28%) and C (71%) fibres. Post-effects of long duration were commonly observed after cessation of the conditioning stimulus. The systemic injection of naloxone (0.3 mg/kg, i.v.) resulted in a partial reduction in these inhibitory effects with a decrease of about 50% for both Aa and C fibre response 10 min after naloxone administration. This was followed by a progressive recovery lasting 30 min. (b) 28 convergent units, including the 15 reported above, were recorded to investigate the effect of naloxone upon the unconditioned response. Responses to Aa fibre were unaffected, whereas the responses to C fibre were slightly (17%) but significantly increased by naloxone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257327     DOI: 10.1016/0006-8993(81)90597-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Alteration of descending modulation of nociception during the course of monoarthritis in the rat.

Authors:  N Danziger; J Weil-Fugazza; D Le Bars; D Bouhassira
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing.

Authors:  Christopher D King; Burel Goodin; Lindsay L Kindler; Robert M Caudle; Robert R Edwards; Nikolaus Gravenstein; Joseph L Riley; Roger B Fillingim
Journal:  J Behav Med       Date:  2012-04-26

Review 3.  Central modulation of pain.

Authors:  Michael H Ossipov; Gregory O Dussor; Frank Porreca
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

Review 4.  Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.

Authors:  A H Dickenson; D Le Bars
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

Review 5.  Spinal opioid systems in inflammation.

Authors:  L Stanfa; A Dickenson
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

6.  DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptors.

Authors:  Yeong-Ray Wen; Chia-Chuan Wang; Geng-Chang Yeh; Sheng-Feng Hsu; Yung-Jen Huang; Yen-Li Li; Wei-Zen Sun
Journal:  J Biomed Sci       Date:  2010-03-19       Impact factor: 8.410

7.  Caerulein and morphine in a model of visceral pain. Effects on the hypotensive response to renal pelvis distension in the rat.

Authors:  H Brasch; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

8.  Effects of traditional "Juci" (contralateral acupuncture) on orofacial nociceptive behavior in the rat.

Authors:  Kosuke Miura; Tomohiro Ohara; Jorge L Zeredo; Yukio Okada; Kazuo Toda; Koji Sumikawa
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

9.  The effect of naloxone on spinal reflexes to electrical and mechanical stimuli in the anaesthetized, spinalized rat.

Authors:  N A Hartell; P M Headley
Journal:  J Physiol       Date:  1991-10       Impact factor: 5.182

10.  Freezing of enkephalinergic functions by multiple noxious foci: a source of pain sensitization?

Authors:  François Cesselin; Sylvie Bourgoin; Annie Mauborgne; Michel Hamon; Daniel Le Bars
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.